Testing the Tests: COVID-19 Antibody Assays Scrutinized for Accuracy by UCSF, UC Berkeley Researchers
A project launched by UC San Francisco and UC Berkeley scientists evaluated some of the more than 120 available antibody test kits.
University of California San Francisco
Give to UCSFA project launched by UC San Francisco and UC Berkeley scientists evaluated some of the more than 120 available antibody test kits.
As people around the world try to envision recovery from the COVID-19 pandemic, much attention has been paid to antibody testing as a way to identify people who have developed immunity to the virus. UCSF experts explain how antibody testing works, who it can be most useful for and why we should be cautious.
A UCSF researcher is among the team that announced promising Phase 1 clinical results for the first new oral polio vaccine in 50 years.
Marilyn Stebbins, a UCSF School of Pharmacy faculty member, shares a firsthand account of being a COVID-19 patient.
UCSF infectious disease researchers and community partners have launched an effort to provide comprehensive, voluntary COVID-19 testing to all residents of two distinctive Bay Area communities.
UCSF is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.
UCSF is announcing that it will provide free COVID-19 sample analysis, indefinitely, to all California Departments of Public Health.